iECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506

  • George Diaz

Press/Media

Period13 Dec 2023

Media coverage

8

Media coverage

  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
    Media name/outletInternational Business Times Australia
    Country/TerritoryAustralia
    Date13/12/23
    PersonsGeorge Diaz
  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date13/12/23
    URLct.moreover.com/?a=52575917604&p=1gw&v=1&x=5mbW_xUDWw87AYveZrB4AA
    PersonsGeorge Diaz
  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506; ECUR-506 is a gene editing-based investigational therapy for the treatment of Ornithine Transcarbamy
    Media name/outletBusiness Wire
    Country/TerritoryUnited States
    Date13/12/23
    PersonsGeorge Diaz
  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
    Media name/outletBioSpace
    Country/TerritoryUnited States
    Date13/12/23
    URLct.moreover.com/?a=52576149853&p=1gw&v=1&x=nNDhp0Q7C5b7JCE0tRuspg
    PersonsGeorge Diaz
  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
    Media name/outletYahoo! Finance
    Country/TerritoryUnited States
    Date13/12/23
    URLct.moreover.com/?a=52576018121&p=1gw&v=1&x=R-gle20rxyrzDV5WqKrYsw
    PersonsGeorge Diaz
  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
    Media name/outletChase
    Country/TerritoryUnited States
    Date13/12/23
    URLct.moreover.com/?a=52575871780&p=1gw&v=1&x=-UzRaZnU_n3PR8TXuA31sA
    PersonsGeorge Diaz
  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
    Media name/outletLe Lezard.com
    Country/TerritoryCanada
    Date13/12/23
    URLct.moreover.com/?a=52575977052&p=1gw&v=1&x=7Z7GvfY_hw2gOilygfFwgQ
    PersonsGeorge Diaz
  • TitleiECURE Secures Clearance from Australian Therapeutic Goods Administration for its Clinical Trial Application for the OTC-HOPE Phase 1/2 Study of ECUR-506
    Media name/outletDaily Item
    Country/TerritoryUnited States
    Date13/12/23
    URLct.moreover.com/?a=52576017839&p=1gw&v=1&x=FfZbzIDNkEbQt6naBvxenw
    PersonsGeorge Diaz